<DOC>
	<DOC>NCT02654652</DOC>
	<brief_summary>The purpose of this study is to determine whether the symbiotic use in patients with head and neck cancer impact on intestinal function after surgical treatment.</brief_summary>
	<brief_title>Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated</brief_title>
	<detailed_description>The study will be conducted offering the patients symbiotic product twice a day for seven days after the surgical treatment. Patients will be monitored for the number of stools, stools consistency, abdominal pain and gas overproduction.</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>head and neck cancer with primary surgical treatment, enteral nutrition by enteral tube. three months antibiotic use earlier the surgery, recently radiotherapy or quimiotherapy, inflammatory bowel disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>